Search
Avita Medical's ReCell regenerative medicine technology.

Avita taps investors for $17m

The company commercialising an innovative spray-on burns treatment co-developed by medical entrepreneur Fiona Wood has launched a $17 million capital raising.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/03/18

1 year TSR5 year TSR
9thAdvance NanoTek1725%106%
293rdRefresh Group23%20%
489thAdvanced Share Registry-7%45%
608thMobilarm-28%-19%
684thAvita Medical-42%-11%
716 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

29/12/17
$75k Bought
29/12/17
$10k Bought
28/12/17
$5k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

90th↑Avita Medical$8.0m
94th↓Refresh Group$6.2m
95th↓Advanced Share Registry$6.0m
97th↓Advance NanoTek$5.1m
98th↓Mobilarm$5.0m
236 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Avita Medical

230thTim Rooney$506k
341stAndrew Quick$366k
612thLorraine Glover$216k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer